Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + isopropyl alcohol + dexamethasone sodium phosphate + lidocaine
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
This appears to be a **topical fixed-dose combination** comprising povidone-iodine, isopropyl alcohol, dexamethasone sodium phosphate, and lidocaine. Pharmacologically, the components suggest a local antiseptic and anesthetic preparation with added anti-inflammatory corticosteroid activity: povidone-iodine provides broad-spectrum microbicidal antisepsis, isopropyl alcohol acts as a rapid skin disinfectant, lidocaine is a local anesthetic that blocks voltage-gated sodium channels to reduce pain, and dexamethasone sodium phosphate is a glucocorticoid receptor agonist used to suppress inflammatory responses. However, the source material provided mainly describes systemic dexamethasone indications and does **not** verify a specific marketed or clinical-stage product corresponding to this exact four-ingredient combination. Accordingly, this annotation treats the entry as a specific combination name but with limited public-source validation for an exact branded asset.
- Other names
- povidone-iodine + isopropyl alcohol + dexamethasone sodium phosphate + lidocaine
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on povidone-iodine + isopropyl alcohol + dexamethasone sodium phosphate + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + isopropyl alcohol + dexamethasone sodium phosphate + lidocaine.